Ono Pharmaceutical Co., Ltd.
OPHLF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $59,328 | $127,977 | $143,532 | $105,025 |
| Dep. & Amort. | $26,894 | $18,140 | $17,451 | $17,721 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $38,337 | -$28,958 | $1,437 | -$30,107 |
| Other Non-Cash | -$42,100 | -$6,499 | -$2,810 | -$30,810 |
| Operating Cash Flow | $82,459 | $110,660 | $159,610 | $61,829 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5,431 | -$4,020 | -$14,497 | -$12,277 |
| Net Acquisitions | -$364,816 | $0 | -$9,151 | -$6,766 |
| Inv. Purchases | -$4,075 | -$36,731 | -$140,591 | -$58,613 |
| Inv. Sales/Matur. | $240,839 | $106,021 | $55,860 | $78,582 |
| Other Inv. Act. | -$3,302 | -$17,193 | $8,120 | $5,112 |
| Investing Cash Flow | -$136,785 | $48,077 | -$100,259 | $6,038 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $135,000 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$1 | -$50,010 | -$1 | -$30,007 |
| Dividends Paid | -$37,516 | -$37,183 | -$29,742 | -$27,666 |
| Other Fin. Act. | -$3,184 | -$2,655 | -$2,741 | -$2,564 |
| Financing Cash Flow | $94,299 | -$89,848 | -$32,484 | -$60,237 |
| Forex Effect | -$1,548 | $1,116 | $155 | $436 |
| Net Chg. in Cash | $38,426 | $70,006 | $27,023 | $8,067 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $166,141 | $96,135 | $69,112 | $61,045 |
| End Cash | $204,567 | $166,141 | $96,135 | $69,112 |
| Free Cash Flow | $74,469 | $89,831 | $145,113 | $49,552 |